Figs Inc Stock Price, News & Analysis

FIGS reported Q1 2025 financial results with net revenues of $124.9 million, up 4.7% year-over-year. The growth was driven by increased orders from existing customers and higher average order value (AOV) of $119, up 2.6%. Scrubwear revenues grew 4.9% to $99.6 million, while non-scrubwear revenues increased 3.8% to $25.3 million. U.S. revenues rose 2.9% to $106 million, and international revenues jumped 16.4% to $18.9 million. However, the company reported a net loss of $0.1 million compared to a $1.4 million profit last year. Gross margin declined 130 basis points to 67.6%. Active customers grew 3.8% to 2.7 million. Due to U.S. tariff impacts, FIGS updated its 2025 outlook, projecting low-single-digit revenue decline and adjusted EBITDA margin of 7.5% to 8.5%.

FIGS (NYSE: FIGS), the global leading healthcare apparel brand, has scheduled its first quarter 2025 earnings release for Thursday, May 8, 2025, after U.S. markets close. The management team will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET on the same day to discuss financial results and business outlook.

A financial highlights presentation will be available on the company's investor relations website prior to the call. The earnings call can be accessed via phone at (833) 470-1428 (US) or +1 404 975 4839 (International) with Conference ID 335422. A replay will be available until May 15, 2025.

FIGS (NYSE: FIGS), the leading healthcare apparel brand, has appointed Jerry Jao as a new independent director to its Board, effective April 1, 2025. Jao, former CEO of Retention Science, will serve as Chair of the Board's Audit Committee and member of the Compensation Committee.

Jao brings extensive marketing, technology, and finance experience to FIGS. He currently serves as SVP and GM at Constant Contact since August 2020, following the acquisition of his AI-powered personalization company, Retention Science. His previous roles include positions at KPMG LLP and Morgan Stanley.

CEO and Co-Founder Trina Spear highlighted that FIGS previously collaborated with Jao's company during the development of their digital marketing engine. Mario Marte, who served as Interim Chair of the Audit Committee since May 2024, will continue as a committee member.

FIGS (NYSE: FIGS) reported its Q4 and full-year 2024 financial results, showing mixed performance. Net revenues grew 1.8% year-over-year to $555.6 million for FY2024, with Q4 revenues up 4.8% to $151.8 million.

Key highlights include:

• FY2024 net income of $2.7 million with 0.5% margin
• Adjusted EBITDA margin of 9.3%, down from 15.8% in 2023
• International revenues increased 30.6% YoY to $81.3 million
• Active customers grew 3.0% to 2.7 million

The company announced a $50 million increase in its share repurchase authorization. For 2025, FIGS plans to reduce promotional activities, which may impact near-term revenue but support long-term brand health.

FIGS (NYSE: FIGS), the global leading healthcare apparel brand, has announced its participation in the upcoming Raymond James 46th Annual Institutional Investors Conference. CEO and Co-Founder Trina Spear and CFO Sarah Oughtred will engage in a fireside chat scheduled for March 3, 2025, at 11:00 a.m. ET.

The event will be accessible to the public through a live audio webcast on the company's investor relations website at https://ir.wearfigs.com. An archive of the presentation will remain available online for 90 days following the event.

FIGS (NYSE: FIGS), the global leading healthcare apparel brand, has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 27, 2025, after U.S. markets close. The management will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET on the same day to discuss financial results, business performance, and outlook.

Prior to the call, FIGS will publish a financial highlights presentation on its investor relations website. A replay of the call will be available until March 6, 2025. The company will use its investor relations website, press releases, SEC filings, and public conference calls to distribute information and comply with Regulation FD disclosure obligations.

Applied Fundamental Research, a long-term shareholder of FIGS, has issued an open letter to the company's management and Board of Directors. The letter commends FIGS' transformation of the healthcare apparel market and outlines recommendations for unlocking shareholder value. The company has achieved notable milestones, including:

- Growing Net Active Customer count by over 500,000
- Managing inventory balance while maintaining brand integrity
- Strengthening leadership through new hires
- Launching the Extremes campaign and Olympic sponsorship

The letter emphasizes the need for a clearly articulated capital allocation strategy, suggesting FIGS should define capital requirements for growth initiatives, prioritize investments, and execute share repurchases to take advantage of current market valuations.

FIGS (NYSE: FIGS), the global healthcare apparel brand, has announced changes to its Board of Directors. Melanie Whelan, former CEO of SoulCycle Inc., will join the board as an independent director effective January 1, 2025. Whelan will serve as Chair of the Board's Compensation Committee and join the Nominating and Corporate Governance Committee. She currently serves as Managing Director at Summit Partners and brings extensive executive experience from roles at SoulCycle, Equinox Holdings, Virgin Management, and Starwood Hotels & Resorts.

The company also announced that A.G. Lafley, who has served on the Board since April 2022, will resign effective December 31, 2024. CEO Trina Spear highlighted Whelan's valuable experience in scaling physical retail presence, which aligns with FIGS' Community Hubs growth strategy.

FIGS released its Q3 2024 financial results, reporting net revenues of $140.2 million, a 1.5% YoY decrease due to a reduction in average order value (AOV). Gross margin fell to 67.1%, impacted by higher discounts and product mix shifts. Operating expenses rose by 17.4% to $102.7 million, driven by increased marketing and fulfillment center transition costs. The company reported a net loss of $1.7 million, down $7.8 million YoY, with a net income margin of -1.2%. Adjusted EBITDA decreased by $19.6 million to $4.8 million. Active customers grew by 3.8% to 2.7 million, but net revenues per active customer and AOV decreased by 3.3% and 5.3%, respectively. FIGS also announced a $25 million minority investment in OOG, an AI-powered platform for healthcare professionals. For FY 2024, FIGS expects net revenues to be down 1% to flat and an adjusted EBITDA margin of ~8%.